Results 1 to 10 of about 709 (114)

Differential complement activation by alloantibodies in sickle cell hyperhaemolysis syndrome may influence disease course

open access: yes
British Journal of Haematology, EarlyView.
Mamie M. Thant   +4 more
wiley   +1 more source

A Rare Case of P‐Null Phenotype Identified During Preoperative Screening

open access: yesClinical Case Reports, Volume 14, Issue 5, May 2026.
ABSTRACT A 46‐year‐old woman scheduled for an elective total abdominal hysterectomy was incidentally found to have a rare P‐null (p) phenotype during routine preoperative testing. Although her ABO/Rh type was A positive, the antibody screen demonstrated strong pan‐reactivity with all panel cells, while the autocontrol was negative, indicating an ...
Alireza Abdollahi   +3 more
wiley   +1 more source

Laryngeal Transplantation in Cancer Patients: Evaluation of Surgical Outcomes and Functional Recovery

open access: yesMedComm, Volume 7, Issue 5, May 2026.
Our pilot clinical study in laryngeal transplantation achieved divergent outcomes: two cases maintained functional speech/swallowing with around 2 year graft survival and have been ongoing, while two succumbed to sepsis (10mo) and hemorrhagic recurrence (11mo).
Zheng Jiang   +9 more
wiley   +1 more source

Improved bilirubin reduction with therapeutic plasma exchange and haemoperfusion in a dog with immune‐mediated haemolytic anaemia

open access: yesVeterinary Record Case Reports, Volume 14, Issue 2, May 2026.
Abstract A 6‐year‐old spayed female Golden Retriever mix was diagnosed with immune‐mediated haemolytic anaemia. Initial treatments included immunosuppression and blood transfusions. With acute mentation decline and rapid increase in serum bilirubin, therapeutic plasma exchange (TPE) was initiated.
Natasha S. Yeh   +2 more
wiley   +1 more source

Understanding the consequences of being RhD immunized during pregnancy 10 years after introduction of targeted routine antenatal anti‐D prophylaxis: A retrospective nationwide cohort study

open access: yesActa Obstetricia et Gynecologica Scandinavica, Volume 105, Issue 5, Page 887-895, May 2026.
In Finland, implementation of targeted routine antenatal anti‐D prophylaxis (RAADP) from 2014 to 2023 resulted in a 64% reduction in maternal anti‐D immunization and fewer cases of severe hemolytic disease of the fetus and newborn requiring intrauterine transfusion, demonstrating the population‐level benefits of targeted national prophylaxis programs ...
Anna Parhamaa   +8 more
wiley   +1 more source

The Use of Pediatric Donors in Pancreas Transplantation

open access: yesClinical Transplantation, Volume 40, Issue 5, May 2026.
ABSTRACT Introduction The use of pediatric donors in simultaneous pancreas‐kidney transplantation (SPKT) and solitary pancreas transplantation is not universally accepted Methods Single center retrospective review of 310 consecutive SPKTs and 50 solitary pancreas transplants performed from 11/1/01 to 1/1/25.
Arianna Cabrales   +7 more
wiley   +1 more source

Survey of quality control testing practices on low titer group O whole blood in the United States

open access: yesTransfusion, Volume 66, Issue S1, Page S82-S86, May 2026.
Abstract Background Use of low titer group O whole blood (LTOWB) continues to increase in the United States (US). This survey sampled the quality control (QC) practices among the largest blood collectors in the US. Methods A survey on LTOWB collection, QC testing, and distribution was developed and electronically distributed to the chief medical ...
Mark H. Yazer   +3 more
wiley   +1 more source

Early exposure, enduring consequences: How do I manage Rh immunoglobulin prophylaxis after Rh‐mismatched transfusions in children?

open access: yesTransfusion, Volume 66, Issue S1, Page S391-S401, May 2026.
Abstract Background RhD mismatched transfusions in RhD negative women have the potential to impact future pregnancies through alloimmunization and development of hemolytic disease of the fetus and newborn (HDFN). As use of RhD positive emergency‐release blood products in pediatric trauma has increased, it has become clear that a significant ...
Kirea Lange   +7 more
wiley   +1 more source

Successful Desensitization with Imlifidase and Daratumumab in a Highly Immunized, Crossmatch Positive, Blood Group-Incompatible Living-Donor Re-Transplant Recipient with Systemic Lupus Erythematosus and Antiphospholipid Syndrome

open access: yesTransfusion Medicine and Hemotherapy
<b><i>Introduction:</i></b> The transplantation of highly sensitized patients remains a major obstacle. Immunized patients wait longer for a transplant if not prioritized, and if transplanted, their transplant outcome is worse.
Schrezenmeier, Eva   +12 more
openaire   +3 more sources

Novel RHCE*cE(341A) allele

open access: yes
Transfusion, Volume 66, Issue 6, Page 1227-1229, June 2026.
Rébecca Voreux   +12 more
wiley   +1 more source

Home - About - Disclaimer - Privacy